2
false
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2024-01-09
Sage Accounts Production Advanced 2024 - FRS102_2024
18,666,667
18,666,667
6,222,223
6,222,223
12,444,444
xbrli:pure
xbrli:shares
iso4217:GBP
15399186
2024-01-09
2025-03-31
15399186
2025-03-31
15399186
2024-01-08
15399186
bus:Director2
2024-01-09
2025-03-31
15399186
core:WithinOneYear
2025-03-31
15399186
core:ShareCapital
2025-03-31
15399186
core:SharePremium
2025-03-31
15399186
core:RetainedEarningsAccumulatedLosses
2025-03-31
15399186
bus:Director1
2024-01-09
2025-03-31
15399186
bus:SmallEntities
2024-01-09
2025-03-31
15399186
bus:AuditExemptWithAccountantsReport
2024-01-09
2025-03-31
15399186
bus:SmallCompaniesRegimeForAccounts
2024-01-09
2025-03-31
15399186
bus:PrivateLimitedCompanyLtd
2024-01-09
2025-03-31
15399186
bus:FullAccounts
2024-01-09
2025-03-31
15399186
core:LicencesFranchises
2024-01-09
2025-03-31
15399186
core:LicencesFranchises
2025-03-31
15399186
core:AllAssociates
2024-01-09
2025-03-31
COMPANY REGISTRATION NUMBER:
15399186
|
Filleted Unaudited Financial Statements |
|
Period from 9 January 2024 to 31 March 2025
|
Statement of financial position |
1 |
|
|
|
Notes to the financial statements |
3 |
|
|
|
Statement of Financial Position |
|
31 March 2025
Fixed assets
|
Intangible assets |
5 |
12,444,444 |
|
|
|
Current assets
|
Debtors |
6 |
25,652 |
|
Cash at bank and in hand |
4,895,060 |
|
------------ |
|
4,920,712 |
|
|
|
|
Creditors: amounts falling due within one year |
7 |
2,804,616 |
|
------------ |
|
Net current assets |
2,116,096 |
|
------------- |
|
Total assets less current liabilities |
14,560,540 |
|
|
|
Provisions
|
Taxation including deferred tax |
3,111,111 |
|
------------- |
|
Net assets |
11,449,429 |
|
------------- |
|
|
Capital and reserves
|
Called up share capital |
1 |
|
Share premium account |
13,999,999 |
|
Profit and loss account |
(
2,550,571) |
|
------------- |
|
Shareholders funds |
11,449,429 |
|
------------- |
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
|
Statement of Financial Position (continued) |
|
31 March 2025
These financial statements were approved by the
board of directors
and authorised for issue on
12 August 2025
, and are signed on behalf of the board by:
Company registration number:
15399186
|
Notes to the Financial Statements |
|
Period from 9 January 2024 to 31 March 2025
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Scale Space Building, 58 Wood Lane, London, W12 7RZ, England.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The accounts have been prepared on a going concern basis which relies upon the continuing support of the investors.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
|
Licensed assets |
- |
33% straight line |
|
|
|
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
4.
Employee numbers
The average number of persons employed by the company during the period amounted to
2
.
5.
Intangible assets
|
Licensed assets |
|
£ |
|
Cost |
|
|
Additions |
18,666,667 |
|
------------- |
|
At 31 March 2025 |
18,666,667 |
|
------------- |
|
Amortisation |
|
|
Charge for the period |
6,222,223 |
|
------------- |
|
At 31 March 2025 |
6,222,223 |
|
------------- |
|
Carrying amount |
|
|
At 31 March 2025 |
12,444,444 |
|
------------- |
|
|
6.
Debtors
|
31 Mar 25 |
|
£ |
|
Trade debtors |
16,766 |
|
Other debtors |
8,886 |
|
-------- |
|
25,652 |
|
-------- |
|
|
7.
Creditors:
amounts falling due within one year
|
31 Mar 25 |
|
£ |
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
391,569 |
|
Corporation tax |
639,260 |
|
Social security and other taxes |
803,739 |
|
Other creditors |
970,048 |
|
------------ |
|
2,804,616 |
|
------------ |
|
|
8.
Related party transactions
Management fees charged from the commonly controlled entity, RQ Biotechnology Limited, amounted to £63,828. The amount due to RQ Biotechnology Limited at 31 March 2025 was £391,569. On 9 April 2024, the business of managing the portfolio of licensed assets was transferred from RQ Biotechnology Holdings Limited to the Company. The assets and liabilities acquired were as follows: Fair value of acquisitions
|
|
|
|
|
£ |
|
Intangible assets - licensed assets |
18,666,667 |
|
Deferred tax |
(4,666,667) |
|
|
------------- |
|
Equity issued |
14,000,000 |
|
|
------------- |
|
|
|